VMC
57
-3
PEG
62
-2
AA
53
-3
LYB
39
-2
DE
62
-3
CHD
47
-6
MTCH
55
2
NSC
60
-2
AON
50
-4
UA
48
-3
INTC
36
-5
WM
76
-3
NWS
90
26
O
20
-2
ETR
63
-3
AMT
45
2
FDX
30
-7
MDT
63
-3
INTU
56
3
STZ
53
-2
VMC
57
-3
PEG
62
-2
AA
53
-3
LYB
39
-2
DE
62
-3
CHD
47
-6
MTCH
55
2
NSC
60
-2
AON
50
-4
UA
48
-3
INTC
36
-5
WM
76
-3
NWS
90
26
O
20
-2
ETR
63
-3
AMT
45
2
FDX
30
-7
MDT
63
-3
INTU
56
3
STZ
53
-2
Financhill
Back

ClearPoint Neuro Quote, Financials, Valuation and Earnings

32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35

CLPT
ClearPoint Neuro

Last Price:
12.74
Seasonality Move:
11.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

ClearPoint Neuro Price Quote

$12.74
+0.74 (+6.17%)
(Updated: December 4, 2024 at 5:55 PM ET)

ClearPoint Neuro Key Stats

Sell
35
ClearPoint Neuro (CLPT) is a Sell
Day range:
$11.83 - $12.15
52-week range:
$5.11 - $14.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
10.37
P/B ratio:
11.41%
Volume:
119.4K
Avg. volume:
218.1K
1-year change:
101.68%
Market cap:
$331M
Revenue:
$24M
EPS:
$-0.69

How Much Does ClearPoint Neuro Make?

Is ClearPoint Neuro Growing As A Company?

  • What Is ClearPoint Neuro's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.41%
  • What Is ClearPoint Neuro's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ClearPoint Neuro Stock Price Performance

  • Did ClearPoint Neuro Stock Go Up Last Month?
    ClearPoint Neuro share price went down by -6.9% last month
  • Did CLPT's Share Price Rise Over The Last Year?
    CLPT share price rose by 101.68% over the past 1 year

What Is ClearPoint Neuro 52-Week High & Low?

ClearPoint Neuro Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ClearPoint Neuro?

  • How Much Debt Does ClearPoint Neuro Have?
    Total long term debt quarterly is $0
  • How Much Cash Does ClearPoint Neuro Have?
    Cash and short term investments quarterly total is $21.6M
  • What Is ClearPoint Neuro’s Book Value Per Share?
    Book value per share is 1.05

Is ClearPoint Neuro Cash Flow Positive?

  • What Is CLPT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.9M
  • What Is ClearPoint Neuro’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $6.3M
  • What Is ClearPoint Neuro’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$200K

ClearPoint Neuro Return On Invested Capital

  • Is Management Doing A Good Job?
    CLPT return on invested capital is -50.18%
  • What Is ClearPoint Neuro Return On Assets?
    ROA measures how assets are converting to revenues and is -38.96%
  • What Is CLPT Return On Equity?
    ROE is a measure of profitability and is -64.36%

ClearPoint Neuro Earnings Date & Stock Price

ClearPoint Neuro Competitors

  • Who Are ClearPoint Neuro's Competitors?
    Below is a list of companies who compete with ClearPoint Neuro or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • InfuSystems Holdings Inc (INFU)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

ClearPoint Neuro Dividend Yield

ClearPoint Neuro Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.85%
Revenue: 40.96% 4.4%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 16.33
Upside from Last Price: 36.11%

Major Shareholders

  • How many CLPT shares are owned by institutional investors?
    11.2M CLPT shares are owned by institutional investors
  • How many CLPT shares are owned by insiders?
    4.2M CLPT shares are owned by insiders